Long-term follow-up of people treated for early choroidal melanoma in the CoMpass trial
Follows adults with early choroidal melanoma who finished the earlier bel-sar trial.
Plain-language title generated from the registry record
Registry title: A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma
Key facts
- Where
- Plzen 23, Prague, and Prague 6, CzechiaSee the 3 sites
- Phase
- Phase 3
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with early choroidal melanoma who took part in the earlier AU-011-301 trial and received bel-sar or sham treatment there. It is a long-term follow-up with no required treatment.
- Age
- 18 years and older
- Sex
- All sexes can join.
- Disease stage
- Early choroidal melanoma (indeterminate lesions or small choroidal melanomas), as studied in the AU-011-301 trial.
- Earlier treatment
- Must have received bel-sar or sham treatment in the AU-011-301 trial.
Read by machine on 9 November 2026.
Where in Czechia
- Fakultni Nemocnice PlzenPlzen 23, CzechiaNot yet recruiting
- Fakultni Thomayerova nemocnicePrague, CzechiaNot yet recruiting
- Ustredni Vojenska Nemocnice Vojenska Fakultni Nemocnice PrahaPrague 6, CzechiaNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Aura Biosciences
- Trial code
- NCT07338968EU 2025-524405-33-00
- Record updated
- 19 August 2026
- Original description
AU-011-403 is a multicenter long-term follow-up safety and efficacy study of subjects with early CM who previously participated in the AU-011-301 Phase 3 trial. There are no required interventions or use of AU-011 (bel-sar) in this long-term follow-up studyRead full original descriptionShow less
A Long-Term Follow-Up Study of Subjects Completing the AU-011-301 (CoMpass) Trial of Bel-sar for Early Choroidal Melanoma (Indeterminate Lesions/Small Choroidal Melanomas)
AU-011-403 is a multicenter long-term follow-up safety and efficacy study of subjects with early CM who previously participated in the AU-011-301 Phase 3 trial. There are no required interventions or use of AU-011 (bel-sar) in this long-term follow-up study
Inclusion: Have received bel-sar or sham treatment in the Aura-sponsored clinical trial AU-011-301; Be willing and able to consent to the AU-011-403 study.
Exclusion: None.